These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 27523924)
1. Reply to a Letter to the Editor: can we really consider tumor size and surgical extent as predictive factors for recurrence in clinically early-stage papillary thyroid carcinoma patients? Roh JL; Kim JW Am J Surg; 2016 Nov; 212(5):1031-1032. PubMed ID: 27523924 [No Abstract] [Full Text] [Related]
2. Can we really consider tumor size and surgical extent as predictive factors for recurrence in clinically early-stage papillary thyroid carcinoma patients? Khosravi MH Am J Surg; 2016 Nov; 212(5):1030-1031. PubMed ID: 27522561 [No Abstract] [Full Text] [Related]
3. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence. Hall CM; Snyder SK; Maldonado YM; Lairmore TC Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047 [TBL] [Abstract][Full Text] [Related]
4. Correlation Between Surgical Extent and Prognosis in Node-Negative, Early-Stage Papillary Thyroid Carcinoma Originating in the Isthmus. Lim ST; Jeon YW; Suh YJ World J Surg; 2016 Feb; 40(2):344-9. PubMed ID: 26446448 [TBL] [Abstract][Full Text] [Related]
5. Recurrence pattern after conservative surgery for papillary thyroid carcinoma. Kobayashi K; Takenouchi S; Mitani H; Yoshida T Auris Nasus Larynx; 2014 Dec; 41(6):548-51. PubMed ID: 24976169 [TBL] [Abstract][Full Text] [Related]
6. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence. Rosário PW; Calsolari MR Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207 [TBL] [Abstract][Full Text] [Related]
7. Oncologic outcomes of robotic thyroidectomy: 5-year experience with propensity score matching. Tae K; Song CM; Ji YB; Sung ES; Jeong JH; Kim DS Surg Endosc; 2016 Nov; 30(11):4785-4792. PubMed ID: 26895921 [TBL] [Abstract][Full Text] [Related]
9. Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma. Kim HJ; Park HK; Byun DW; Suh K; Yoo MH; Min YK; Kim SW; Chung JH Head Neck; 2015 May; 37(5):650-4. PubMed ID: 24590814 [TBL] [Abstract][Full Text] [Related]
10. Prognostic factors of insular versus papillary/follicular thyroid carcinoma. Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957 [TBL] [Abstract][Full Text] [Related]
11. Impact of tall cell variant histology on predicting relapse and changing the management of papillary thyroid carcinoma patients. Gunalp B; Okuyucu K; Ince S; Ayan A; Alagoz E Hell J Nucl Med; 2017; 20(2):122-127. PubMed ID: 28697188 [TBL] [Abstract][Full Text] [Related]
12. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis. Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314 [TBL] [Abstract][Full Text] [Related]
13. Metastatic papillary thyroid cancer with lateral neck disease: pattern of spread by level. Merdad M; Eskander A; Kroeker T; Freeman JL Head Neck; 2013 Oct; 35(10):1439-42. PubMed ID: 22965902 [TBL] [Abstract][Full Text] [Related]
14. The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer. Wang F; Yu X; Shen X; Zhu G; Huang Y; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Wang Y; Liu S; Zhao J; Zhao S; Xing M J Clin Endocrinol Metab; 2017 Sep; 102(9):3241-3250. PubMed ID: 28582521 [TBL] [Abstract][Full Text] [Related]
15. Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer. Wang C; Chen X; Wei X; Chen F; Wang Y; Shen Z Asian J Surg; 2017 Jan; 40(1):55-60. PubMed ID: 27697309 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of extrathyroidal extension according to primary tumor size in papillary thyroid carcinoma. Liu L; Oh C; Heo JH; Park HS; Lee K; Chang JW; Jung SN; Koo BS Eur J Surg Oncol; 2018 Nov; 44(11):1754-1759. PubMed ID: 29934055 [TBL] [Abstract][Full Text] [Related]
17. Apparently intrathyroid papillary thyroid carcinoma >1 and ≤4 cm: is the need for completion thyroidectomy common among patients submitted to lobectomy? Rosario PW; Mourão GF; Calsolari MR Clin Endocrinol (Oxf); 2016 Jul; 85(1):150-1. PubMed ID: 26840381 [No Abstract] [Full Text] [Related]
18. MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer. Sondermann A; Andreghetto FM; Moulatlet AC; da Silva Victor E; de Castro MG; Nunes FD; Brandão LG; Severino P Clin Exp Metastasis; 2015 Aug; 32(6):521-30. PubMed ID: 26007293 [TBL] [Abstract][Full Text] [Related]
19. Treatment Outcomes and Risk Factors for Recurrence After Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma. Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY Thyroid; 2016 Feb; 26(2):262-70. PubMed ID: 26566765 [TBL] [Abstract][Full Text] [Related]
20. Long-Term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study. Hwangbo Y; Kim JM; Park YJ; Lee EK; Lee YJ; Park DJ; Choi YS; Lee KD; Sohn SY; Kim SW; Chung JH; Lim DJ; Kim MH; Kim MJ; Jo YS; Shong MH; Koong SS; Hahm JR; Jung JH; Yi KH J Clin Endocrinol Metab; 2017 Feb; 102(2):625-633. PubMed ID: 27732329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]